www.wada-ama.org/en/resources/2026-monitoring-program Sport Resolutions
Our clinical decisions are guided by: The strength and quality of available evidence Individual medical and psychiatric history Safety, side-effect profiles, and long-term risk How any new approach integrates with comprehensive, whole-person care If GLP-1 medications eventually prove safe and effective for certain patients with substance use disorders, they would be considered as part of a broader, medically directed treatment plannever as a standalone quick fix. In the meantime, my advice to patients is straightforward: have this conversation with your treatment team
References References Pickart, L., & Margolina, A
Start by ensuring clinics use FDA-approved branded medications rather than compounded ones, guaranteeing safety and effectiveness
Find articles by Beaudry, J